Ready to grow your business?
Are you contemplating an IPO? Do you know what it takes to be prepared? Or ...
Read MoreThe headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember:
Get our executive insight into your inbox
Written By
Lea Bidiville
17 August 2017
Are you contemplating an IPO? Do you know what it takes to be prepared? Or ...
Read MoreEach year the Biotech and Money Assembly and Awards recognises the UK’s gre...
Read MoreOn the 27th June, we spoke to an expert panel to discuss the how, when, wha...
Read MoreDealing with the challenges of growing your business it can turn really per...
Read MoreBy Kristian Wiggert Partner Covington & Burling LLP, London The recent stro...
Read MoreBiotech companies have fared well recently in the IPO market in both the US...
Read MoreNew acquisition vehicle Levrett comes online and immediately targets promis...
Read MoreBiotech and Money are pleased to announce the release of the latest Drugs &...
Read MoreBiotech and Money are pleased to announce the release of the latest Drugs &...
Read MoreBiotech and Money are pleased to announce the release of the latest Drugs &...
Read More3 months into his tenure as CEO of NetScientific, the vastly experienced in...
Read MoreNew York is a hotbed of life science innovation, yet the city has never qui...
Read MoreThe Drugs & Dealers Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
In partnership with Medius Associates
Medius' monthly review of the top deals by value in the healthcare sector
Connecting Europe's Life Science corporates with capital.
Biotech and Money is the influential community of senior life science decision makers
© 2016 All Rights Reserved By Biotech and Money
Add Your Response